Patrick Rispal
Impact in
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- COVID-19 Clinical Research Studies 5
- HIV/AIDS drug development and treatment 4
-
- HIV-related health complications and treatments 7
- Co-authors
- B Leng (12 shared papers)Jean‐Luc Pellegrin (7 shared papers)Gisèle Clofent‐Sanchez (4 shared papers)Paquita Nurden (4 shared papers)Alan T. Nurden (4 shared papers)Laurent Macchi (1 shared paper)JL Pellegrin (8 shared papers)Jean‐François Viallard (2 shared papers)
- Journals
- Clinical Infectious Diseases (4 papers)Scientific Reports (3 papers)British Journal of Haematology (2 papers)Emerging infectious diseases (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- FranceUnited KingdomCanada
In The Last Decade
Patrick Rispal
50 papers receiving 764 citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 238
- Virology 59
- Emergency Medicine 98
- Hematology 126
- Microbiology 7
Countries citing papers authored by Patrick Rispal
This map shows the geographic impact of Patrick Rispal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Rispal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Rispal more than expected).
Fields of papers citing papers by Patrick Rispal
This network shows the impact of papers produced by Patrick Rispal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Rispal. The network helps show where Patrick Rispal may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Rispal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 93 | |
| 2 | 2021 | 60 | |
| 3 | 2022 | 58 | |
| 4 | 1996 | 49 | |
| 5 | 2003 | 47 | |
| 6 | 1995 | 45 | |
| 7 | 2008 | 39 | |
| 8 | 2023 | 36 | |
| 9 | 2021 | 32 | |
| 10 | High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries. | 2006 | 26 |
| 11 | 2016 | 25 | |
| 12 | 2001 | 25 | |
| 13 | 2022 | 23 | |
| 14 | 1996 | 21 | |
| 15 | 1996 | 20 | |
| 16 | 2024 | 19 | |
| 17 | 2000 | 14 | |
| 18 | 2023 | 13 | |
| 19 | The DAD Study Group. Combination antiretroviral therapy and the risk of myocardial infarction | 2003 | 13 |
| 20 | 2023 | 13 |
About Patrick Rispal
Patrick Rispal is a scholar working on Infectious Diseases, Emergency Medicine, Hematology, Rheumatology and Critical Care and Intensive Care Medicine, having authored 55 papers that have together received 811 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (7 papers), COVID-19 Clinical Research Studies (5 papers), Platelet Disorders and Treatments (5 papers), Blood groups and transfusion (4 papers), HIV/AIDS drug development and treatment (4 papers), Autoimmune Bullous Skin Diseases (3 papers), Complement system in diseases (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Infectious Diseases (238 citations), Virology (59 citations), Emergency Medicine (98 citations), Hematology (126 citations) and Microbiology (7 citations). Patrick Rispal has collaborated with scholars based in France, United Kingdom and Canada. Frequent co-authors include B Leng, Jean‐Luc Pellegrin, Gisèle Clofent‐Sanchez, Paquita Nurden, Alan T. Nurden, Laurent Macchi, JL Pellegrin, Jean‐François Viallard, J. Constans and Sophie Lucas. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports, British Journal of Haematology, Emerging infectious diseases and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.